Rupe, Carl H – Trademark Portfolio

Entity Type: 01

Rupe, Carl H holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include PRODUXUS and MYPREFERENCE. The owner is based in Roanoke Rapids, NC.

P.O. Box 57

Roanoke Rapids, NC 27870

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PRODUXUS
PRODUXUS
Registered 2019
RSVP
RSVP
Abandoned 2016
PRODUXUS
PRODUXUS
Abandoned 2016

Trademark Classifications

Rupe, Carl H's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Rupe, Carl H have?

Rupe, Carl H has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does Rupe, Carl H file in?

Rupe, Carl H files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are Rupe, Carl H's most well-known trademarks?

Rupe, Carl H's registered trademark portfolio includes well-known marks such as PRODUXUS and MYPREFERENCE. These are among 2 currently registered trademarks in the portfolio.

What is Rupe, Carl H's trademark registration success rate?

Rupe, Carl H has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.